Sue --

I was at a Continuing Education Conference for Head and Neck Cancer at Johns Hopkins last Friday and several of the doctors (surgeons, medical oncologists) reported that over 50% of their NEW patients are non-smokers. There is a changing demographic for HNC, a talk by Dr. Maura Gillison on her research outlined that quite clearly. Patients are younger, often non-smokers, and more oropharyngeal cancers than nasopharyngeal. A fair number of unknown primaries, too.

Let us know how the Erbitux works, it is only recently been used outside of the clinical trial setting.

Best of luck to you and your Dad, be strong, it is a long road but there is hope at the end...

Gail